Oncoheroes Biosciences Inc.

Website http://www.oncoheroes.com

Founded 2017

Employees 10

Follow

Overview

Oncoheroes is the first biotech company in the world 100% focused on discovering, developing and commercializing new therapies for children and adolescents with cancer. We intend to become the global leader in delivering new pediatric oncology drugs.

Management Team

Founder | Board of Directors | CEO

Ricardo Garcia

Ricardo is a natural-born serial entrepreneur. He sold his first company at the age of 22. This led to the creation and development of various companies with a strong bent towards innovation. The cancer diagnosis of his son motivated him to create Oncoheroes Biosciences and the Richi Childhood Cancer Foundation, a 501 (c) (3) non profit organization established in the US and with links around the world.

Founder | Board of Directors | Chief Operating Officer

Cesare Spadoni

Cesare has more than 20 years of experience in the drug development field. Following the death of his first daughter Laura to cancer, Cesare set up aPODD Foundation, a London-based charity focused on accelerating paediatric oncology drug development. Cesare holds an MSc in Applied Molecular Biology and a PhD in Neurosciences from UCL, University of London, as well as an MBA from the Central European University, Budapest.

Chief Scientific Officer

Michel Janicot PhD

Michel was Senior Director at Janssen (Johnson & Johnson; Beerse. Belgium), where he was involved in early clinical development of novel oncology drug candidates, scientific licensing and strategic partnering. Prior to this, Michel served as Associate Research Fellow at Rhone-Poulenc Rorer (Paris. France) and was postdoctoral fellow at The Johns Hopkins University (Baltimore, MD. USA) in the department of Biological Chemistry.

Head of Clinical Development

Wouter Wijker PhD

Wouter started his career as a researcher in human electrophysiology at the University of Amsterdam. Afterwards he took on a position as biostatistician at the Academic Medical Centre of the University of Amsterdam and was mainly involved in setting up and analysing clinical studies. Wouter founded BwO Research BV, a clinical research organization assisting several large and international pharmaceutical companies in human drug research.

Chief Discovery Officer

Eva Mendez

Eva has more than 17 years of experience in academic and industrial biomedical research. She was head of several drug discovery departments and strategy at Ferrer Group. Eva is a member of the Business Advisory Board of the Institute of Research in Biomedicine of Barcelona (IRB Barcelona) and an advisor for European Collaborative Research Projects.

Head of Regulatory Affairs

Evgenia Mengou

Evie Mengou is a seasoned regulatory affairs professional, with over 20 years’ experience in pharmaceutical drug development spanning several therapeutic areas, involving small molecules and biologics. Following the introduction of Paediatric Regulation in Europe, she has been involved in leading the preparation, negotiation and execution of paediatric investigation plans and paediatric clinical trials.

Head of Patient Advocacy and Community Engagement

Jonathan Agin

Jonathan has significant legal, biotech, non-profit/for profit organizational, managerial and advocacy experience. Having spent over 19 years in the practice of law, 16 of which were as a full time litigator in Washington, DC and Maryland, he transitioned from legal practice and the law firm that he co-founded following the loss of his daughter Alexis to pediatric brain cancer (DIPG) in January 2011.